Multiple Sclerosis International Federation (MSIF) is a private-limited-guarant-nsc-limited-exemption company established in 2004, dedicated to supporting individuals living with multiple sclerosis (MS). The organization operates internationally, focusing on research, education, and advocacy for the MS community. MSIF’s core mission centers around improving the quality of life for individuals affected by MS through the provision of resources, support networks, and collaborative initiatives. The company provides a platform for sharing knowledge, facilitating peer support groups, and promoting advancements in MS treatment and management. Specifically, MSIF offers a range of services including information dissemination, clinical trial participation assistance, and advocacy for improved patient access to specialized care. The organization’s international presence is significant, with offices and collaborators spanning Europe, North America, and Asia. The company’s size is estimated to be relatively small, focusing primarily on strategic planning and operational management. MSIF’s key focus is on the well-being of the MS community, leveraging its expertise to address challenges and promote a better future for individuals living with this complex neurological disorder. The company’s SIC industry focus includes healthcare, medical research, and support services for individuals with disabilities.

Multiple Sclerosis International Federation (MSIF) is a private-limited-guarant-nsc-limited-exemption company established in 2004, dedicated to supporting individuals living with multiple sclerosis (MS). The organization operates internationally, focusing on research, education, and advocacy for the MS community. MSIF’s core mission centers around improving the quality of life for individuals affected by MS through the provision of resources, support networks, and collaborative initiatives. The company provides a platform for sharing knowledge, facilitating peer support groups, and promoting advancements in MS treatment and management. Specifically, MSIF offers a range of services including information dissemination, clinical trial participation assistance, and advocacy for improved patient access to specialized care. The organization’s international presence is significant, with offices and collaborators spanning Europe, North America, and Asia. The company’s size is estimated to be relatively small, focusing primarily on strategic planning and operational management. MSIF’s key focus is on the well-being of the MS community, leveraging its expertise to address challenges and promote a better future for individuals living with this complex neurological disorder. The company’s SIC industry focus includes healthcare, medical research, and support services for individuals with disabilities.